Related Experiment Video
Updated: Jul 7, 2026
10:48
Generation of Human Motor Units with Functional Neuromuscular Junctions in Microfluidic Devices
Published on: September 7, 2021
Neuropathy target esterase gene mutations cause motor neuron disease
Shirley Rainier1, Melanie Bui, Erin Mark
1Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA.
American Journal of Human Genetics
|March 4, 2008
Summary
Mutations in the neuropathy target esterase (NTE) gene cause motor neuron disease (MND) and axonal degeneration. This finding suggests NTE pathway dysfunction may contribute to other neurodegenerative conditions like ALS.
Area of Science:
- Neuroscience
- Genetics
- Toxicology
Background:
- Organophosphorus (OP) compounds are linked to motor neuron disease (MND), with evidence from paraoxonase 1 polymorphisms in amyotrophic lateral sclerosis (ALS) and OP compound-induced delayed neuropathy (OPIDN).
- OPIDN involves inhibition of neuropathy target esterase (NTE) by organophosphorylation, leading to neuropathy.
- Previous studies suggest a connection between OP exposure, NTE inhibition, and neurodegenerative pathways.
Purpose of the Study:
- To investigate the genetic basis of a progressive spastic paraplegia and distal muscle wasting disorder in two kindreds.
- To determine if mutations in the neuropathy target esterase (NTE) gene are associated with this motor neuron disease.
- To explore the role of NTE in maintaining axonal integrity and its potential contribution to other forms of MND.
Main Methods:
- Evaluated two kindreds (one consanguineous, one nonconsanguineous) with progressive spastic paraplegia and distal muscle wasting.
- Performed genome-wide analysis to identify linkage loci, focusing on chromosome 19p13 where NTE is mapped.
- Conducted genetic linkage and sequence analysis of the NTE gene in affected individuals.
Main Results:
- Genome-wide analysis identified a significant linkage locus on chromosome 19p13 in the consanguineous kindred.
- Identified homozygous and compound heterozygous mutations in the NTE gene in affected individuals from both kindreds.
- These disease-specific NTE mutations disrupted conserved residues in the catalytic domain or led to protein truncation.
Conclusions:
- Mutations in the neuropathy target esterase (NTE) gene are causative of a progressive motor neuron disease.
- NTE is crucial for maintaining axonal integrity, and its dysfunction may contribute to other neurodegenerative disorders, including ALS.
- Abnormalities in the NTE pathway are implicated in the axonopathy observed in neuropathic OP compound exposure.
More Related Videos
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...